바로가기 메뉴
본문 바로가기
주메뉴 바로가기
푸터 바로가기

IRB

It creates a protective environment for research subjects and promotes ethical research practices​

The Institutional Review Board (IRB)​

The Institutional Review Board (IRB) of the Korean National Tuberculosis Association operates autonomously and independently to review the ethical and scientific validity of research conducted by the association, ensuring the dignity, rights, safety, and welfare of research participants and human biological materials donors in accordance with the 'Bioethics and Safety Act’​

Scope of IRB Operation:​

  • Human subject research​
  • Human-derived material research​

Functions of IRB:​

  • Reviewing the ethical validity of research proposals submitted when selecting projects for tuberculosis research internally and externally​
  • Determining the permissibility and scope of research that may have serious ethical and social implications among tuberculosis research projects​
  • Establishing ethical guidelines and research guidelines for tuberculosis research​
  • Conducting education on research ethics​
  • Ensuring appropriate consent from research participants (patients or subjects)​
  • Addressing the safety, protection of personal information, and compensation for harm of research participants (patients or subjects)​
  • Handling requests for review related to tuberculosis research and government-designated institution testing​

Certification Status

  • Ministry of Food and Drug Safety (MFDS) Designation No. 178​

    Designation as a Clinical Trial Laboratory (GCLP) in March 2020.

  • Korea Centers for Disease Control and Prevention (KCDC), Registration No. 1-70010013-AB-N-01​

    Designation as a Clinical Trial Laboratory (GCLP) in March 2020.​

Contact